Singular Genomics Systems Inc
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and spatial multiomics technology for researchers and clinicians to advance science and medicine. It is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection wit… Read more
Market Cap & Net Worth: Singular Genomics Systems Inc (OMIC)
Singular Genomics Systems Inc (NASDAQ:OMIC) has a market capitalization of $50.77 Million ($50.77 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #22671 globally and #7997 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Singular Genomics Systems Inc's stock price $20.01 by its total outstanding shares 2537020 (2.54 Million).
Singular Genomics Systems Inc Market Cap History: 2021 to 2025
Singular Genomics Systems Inc's market capitalization history from 2021 to 2025. Data shows change from $879.84 Million to $50.77 Million (-62.94% CAGR).
Singular Genomics Systems Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Singular Genomics Systems Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
12.03x
Singular Genomics Systems Inc's market cap is 12.03 times its annual revenue
169.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $152.98 Million | $765.00K | -$88.27 Million | 199.98x | N/A |
| 2023 | $35.01 Million | $2.91 Million | -$94.82 Million | 12.03x | N/A |
Competitor Companies of OMIC by Market Capitalization
Companies near Singular Genomics Systems Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Singular Genomics Systems Inc by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #98 globally with a market cap of $170.40 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #263 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #362 globally with a market cap of $61.18 Billion USD ( €59.61 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #472 globally with a market cap of $45.90 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #98 | Intuitive Surgical Inc | NASDAQ:ISRG | $170.40 Billion | $482.76 |
| #263 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #362 | EssilorLuxottica S. A. | PA:EL | $61.18 Billion | €203.00 |
| #472 | Becton Dickinson and Company | NYSE:BDX | $45.90 Billion | $161.64 |
Singular Genomics Systems Inc Historical Marketcap From 2021 to 2025
Between 2021 and today, Singular Genomics Systems Inc's market cap moved from $879.84 Million to $ 50.77 Million, with a yearly change of -62.94%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $50.77 Million | +2.99% |
| 2024 | $49.29 Million | +40.80% |
| 2023 | $35.01 Million | -77.11% |
| 2022 | $152.98 Million | -82.61% |
| 2021 | $879.84 Million | -- |
End of Day Market Cap According to Different Sources
On Feb 20th, 2026 the market cap of Singular Genomics Systems Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $50.77 Million USD |
| MoneyControl | $50.77 Million USD |
| MarketWatch | $50.77 Million USD |
| marketcap.company | $50.77 Million USD |
| Reuters | $50.77 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.